乳腺癌基于价值的患者为中心结局标准集:国际健康结局测量联盟(ICHOM)倡议
国际健康结局测量联盟(ICHOM)组建26名医疗提供者与患者倡导者的多学科国际工作组,通过8次电话会议、改良两轮德尔菲法、患者焦点小组(8例早期或转移性乳腺癌患者)及1225例跨国乳腺癌患者和幸存者在线匿名调查,制定乳腺癌基于价值的患者为中心结局标准集。该标准集涵盖生存与癌症控制、治疗负效用(如急性治疗并发症),推荐组合多种患者报告结局测量工具捕捉长期健康程度,并建议基线采集选定病例组合因素。
要点
- 标准集涵盖生存与癌症控制及治疗负效用(如急性治疗并发症)结局。
- 推荐组合多种患者报告结局测量工具捕捉长期健康程度结局。
- 建议基线采集选定的病例组合因素。
核心结论
- ICHOM制定乳腺癌基于价值的患者为中心结局标准集,涵盖生存与癌症控制、治疗负效用,推荐组合多种患者报告结局测量工具捕捉长期健康程度,建议基线采集选定病例组合因素。
研究设计与样本
- ICHOM组建26名医疗提供者与患者倡导者的多学科国际工作组,通过8次电话会议及每次会后随访调查,采用改良两轮德尔菲法达成共识。
- 通过8例早期或转移性乳腺癌患者焦点小组会议及1225例跨国乳腺癌患者和幸存者在线匿名调查获取患者意见。
主要发现
- 标准集涵盖生存与癌症控制及治疗负效用(如急性治疗并发症)结局,通过行政数据和/或临床记录采集。
- 推荐组合多种患者报告结局测量工具捕捉长期健康程度结局。
- 建议基线采集选定的病例组合因素。
关键数值与推荐
- 推荐组合多种患者报告结局测量工具捕捉长期健康程度结局。
- 建议基线采集选定的病例组合因素。
临床怎么用
- ICHOM将努力实现该标准集的广泛接受,并促进其在全球不同环境和机构的常规临床实践中实施。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A major challenge in value-based health care is the lack of standardized health outcomes measurements, hindering optimal monitoring and comparison of the quality of health care across different settings globally. The International Consortium for Health Outcomes Measurement (ICHOM) assembled a multidisciplinary international working group, comprised of 26 health care providers and patient advocates, to develop a standard set of value-based patient-centered outcomes for breast cancer (BC). The working group convened via 8 teleconferences and completed a follow-up survey after each meeting. A modified 2-round Delphi method was used to achieve consensus on the outcomes and case-mix variables to be included. Patient focus group meetings (8 early or metastatic BC patients) and online anonymized surveys of 1225 multinational BC patients and survivors were also conducted to obtain patients' input. The standard set encompasses survival and cancer control, and disutility of care (eg, acute treatment complications) outcomes, to be collected through administrative data and/or clinical records. A combination of multiple patient-reported outcomes measurement (PROM) tools is recommended to capture long-term degree of health outcomes. Selected case-mix factors were recommended to be collected at baseline. The ICHOM will endeavor to achieve wide buy-in of this set and facilitate its implementation in routine clinical practice in various settings and institutions worldwide.
引用
- Ong WL, Schouwenburg MG, van Bommel ACM, et al. A Standard Set of Value-Based Patient-Centered Outcomes for Breast Cancer: The International Consortium for Health Outcomes Measurement (ICHOM) Initiative. JAMA Oncol. 2017. PMID: 28033439. doi:10.1001/jamaoncol.2016.4851
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。